Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

Weill Cornell and NewYork-Presbyterian create pioneering Institute for Precision Medicine

Recognizing that medicine is not "one size fits all," Weill Cornell Medical College and NewYork-Presbyterian Hospital have created the pioneering Institute for Precision Medicine at Weill Cornell and NewYork-Presbyterian/Weill Cornell Medical Center. This new, cutting-edge translational medicine research hub will explore the new frontier of precision medicine, offering optimal targeted, individualized treatment based on each patient's genetic profile.

1 Feb 2013

First Edition: February 1, 2013

Kaiser Health News staff writer Jenny Gold, working in collaboration with NPR, reports: "As of mid-January, most of NYU is up and running again, including the labor and delivery unit. But the question still looms whether NYU will lose some of the patients and even doctors who sought refuge at NYU's biggest competitors after the storm. If that happens, the storm could end up having a long term impact on NYU's valuable share of the fiercely competitive health care market in New York City."

1 Feb 2013

DoD releases new biofeedback smart phone mobile app for service members

The Department of Defense has released a smart phone mobile application to help service members use the therapeutic benefits of biofeedback.

1 Feb 2013

DelMar announces second closing of $1.5M in private placement

DelMar Pharmaceuticals, Inc. today announced the second closing in a private placement consisting of approximately 1.9 million units of its securities to qualified accredited investors, for gross proceeds of approximately $1.5 million. The total amount raised in the private placement is $6.9 million.

31 Jan 2013

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Pfizer Inc. said today that the United States District Court for the District of Delaware ruled that Pfizer's patent covering a method for using sirolimus, the active ingredient in RAPAMUNE®, for the inhibition of organ transplant rejection is valid and infringed.

31 Jan 2013

Language processing deficits may occur at stuttering onset

A study of preschool-age children has shown key differences in the neural networks mediating language processing between those who stutter and those who do not.

31 Jan 2013

Hyperconnectivity in brain emotion regions even in remitted bipolar I disorder

Bipolar I disorder patients who are in remission display increased coupling between brain regions involved in regulating emotions, even in the absence of a psychological task, shows a US study.

31 Jan 2013

Cerebrolysin: a promising new treatment for dementia

Dementia patients may benefit from a promising new treatment called Cerebrolysin, according to the results of a systematic review published in The Cochrane Library. The authors brought together the most up-to-date evidence on Cerebrolysin as a treatment for vascular dementia.

31 Jan 2013

Congenital sight impairment cure grows closer

A cure for congenital sight impairment caused by lens damage is closer following research by scientists at Monash University.

31 Jan 2013

State roundup: Ga. hospital fee bill nears passage

After a series of friendly questions and statements of support, the fast-tracked legislation on a state hospital provider fee swept through a House committee Tuesday. The House Government Affairs Committee, by a 15-1 vote, approved Senate Bill 24, which would facilitate the renewal of the assessment. The state Senate passed the bill earlier this month. The legislation could reach the House floor Thursday or Friday. If it passes, it then would go to Gov. Nathan Deal for his signature -- an unusually rapid journey into law.

31 Jan 2013

Nursing-home operators face credit crunch

The Wall Street Journal reports that instability in the health care environment is making banks hesitant to give mortgages to nursing homes.

From Elekta 31 Jan 2013

Review article highlights growing evidence for lasting impact of alcohol on the brain

Excessive alcohol use accounts for 4% of the global burden of disease, and binge drinking particularly is becoming an increasing health issue. A new review article published Cortex highlights the significant changes in brain function and structure that can be caused by alcohol misuse in young people.

31 Jan 2013

FET programme picks Graphene and HumanBrain among six visions for frontier research

Europe is set to embark on two bold, visionary projects. The projects aim to invest up to one billion euroover ten years to fuel revolutionary discoveries. The Future and Emerging Technologies Flagship (FET) programme picked two among six visions for frontier research.

31 Jan 2013

Pipeline embolization device safe and effective tool for patients with brain aneurysms

A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline embolization device, is a flow diverter that redirects blood flow away from wide-necked or giant aneurysms that cannot be treated in more conventional ways.

31 Jan 2013

Genentech announces positive results from GA101 plus chlorambucil Phase III study on CLL

Genentech, a member of the Roche Group, today announced positive results from Stage 1 of CLL11, a Phase III randomized study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil chemotherapy compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL).

31 Jan 2013

Binge drinking causes insulin resistance and increases risk of Type 2 diabetes

Binge drinking causes insulin resistance, which increases the risk of Type 2 diabetes, according to the results of an animal study led by researchers at the Diabetes Obesity and Metabolism Institute at the Icahn School of Medicine at Mount Sinai.

31 Jan 2013

RBC Life Sciences receives U.S. patent for Neurobright supplement

RBC Life Sciences, Inc., has been granted US Patent 8357422, which protects its unique dietary supplement formulation that nutritionally supports cognitive function, learning and remembering. The Company markets this supplement under the name "Neurobright."

31 Jan 2013

Positive moods can improve decision making and working memory in older people

Older adults can improve their decision making and working memory simply by putting on a happy face, a new study suggests.

31 Jan 2013

Supplementation with omega-3 fatty acids promotes effective immune system response

Supplementation with omega-3 fatty acids promotes effective immune system response and has ameliorating effects on chronic inflammation (a condition caused by an imbalanced immune system that can lead to multiple serious illnesses over time), according to the most recent study published by the National Center for Biotechnology Information on the effects of omega-3.

31 Jan 2013

Erbin protein critical to brain excitement

Scientists have found an early step in how the brain's inhibitory cells get excited. A natural balance of excitement and inhibition keeps the brain from firing electrical impulses randomly and excessively, resulting in problems such as schizophrenia and seizures. However excitement is required to put on the brakes.

31 Jan 2013